NRX Pharmaceuticals Inc (NAS:NRXP)
$ 4.11 -0.37 (-8.26%) Market Cap: 175.91 Mil Enterprise Value: 170.13 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

NRX Pharmaceuticals Inc Corporate Update Conference Call Transcript

Dec 2, 2025 / 02:00 PM GMT
Release Date Price: $2.27 (-5.02%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NRXP.OQ - NRX Pharmaceuticals Inc
NRX Pharmaceuticals Inc Corporate Update Conference Call
Dec 02, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone and welcome to the Anorex Pharmaceuticals Incorporate update call. Currently all participants are in a listen-only mode. As a reminder, this conference call is being recorded. I will now turn the call over to Brian Korb. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and welcome everyone.

Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under US Federal securities law. These statements are subject to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot